Actinic keratosis is a common skin lesion that develops as a result of chronic ultraviolet exposure and is classified as a premalignant (pre-cancerous) condition. Because of its potential to progress to squamous cell carcinoma if left untreated, it occupies an important clinical position in dermatology. In 2026, the variety of treatment options and early intervention approaches are positively influencing patient outcomes.
What Is Actinic Keratosis?
Actinic keratosis arises when keratinocyte cells in the outermost layer of the epidermis undergo dysplastic changes as a result of cumulative UV damage. Clinically, it presents as dry, rough, crusty lesions that typically range from a few millimetres to a few centimetres in size. They may be pink, red, or skin-coloured and are often more easily felt than seen — exhibiting a sandpaper-like texture.
Which Areas Are Affected?
Actinic keratosis lesions appear primarily on body areas that are chronically exposed to the sun. The most frequently affected sites include:
- Face, especially the forehead, nose, and cheeks
- Bald scalp
- Ear helices
- Backs of the hands and forearms
- Neck and décolletage
- Lower lip (referred to as actinic cheilitis)
Significance as a Pre-Cancerous Condition
Actinic keratosis is regarded as the in situ stage of squamous cell carcinoma (SCC). Although the likelihood of a single actinic keratosis lesion progressing to invasive squamous cell carcinoma is low, the cumulative risk in patients with multiple lesions reaches a clinically significant level. Because it cannot be predicted which lesion will progress, treatment of all actinic keratosis lesions is recommended.
Risk Factors
The principal risk factors for the development of actinic keratosis are:
- Cumulative sun exposure: Outdoor workers and older individuals who have been exposed to the sun for many years are at the highest risk.
- Fair skin: Individuals with Fitzpatrick skin types I and II are more susceptible.
- Advanced age: Lesions are most frequently seen in people over fifty years of age.
- Immunosuppression: Both the incidence and the risk of malignant transformation are increased in immunocompromised individuals.
- Geographic location: Individuals living in areas close to the equator or at high altitudes are exposed to more intense UV radiation.
Current Treatment Approaches in 2026
Lesion-Directed Treatments
Cryotherapy (freezing with liquid nitrogen) is the most widely used method and produces effective results for single or few lesions. Curettage and electrodesiccation may also be preferred for thicker lesions.
Field Treatments
Topical therapies are prominent for patients with numerous lesions. Agents such as 5-fluorouracil, imiquimod, diclofenac, and tirbanibulin are used for treating large areas. Photodynamic therapy (PDT) is based on the principle of applying a photosensitising agent followed by targeted light of a specific wavelength, offering cosmetically superior outcomes.
Combination Approaches
Current guidelines recommend the combined use of lesion-directed and field therapies, particularly for widespread areas of actinic keratosis.
Prevention
Sunscreen use is the cornerstone of preventing the development of actinic keratosis. Broad-spectrum products with SPF 50 or higher should be applied daily and supplemented with physical protection measures.
Conclusion
At Virtuana Clinic, we apply current dermatological protocols in the diagnosis and treatment of actinic keratosis. We recommend seeking a dermatological evaluation without delay whenever you notice rough, crusty, or non-healing lesions on your skin.
This article is for informational purposes only. Please consult a qualified physician for treatment decisions.